Michael J. Parnham

Frankfurt Am Main, HE, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 91 publications

The Effect of the Novel Macrolide Glasmacinal (EP395) on Allergen-Induced Eosinophil Infiltration into the Lung.

The Effect of the Novel Macrolide Glasmacinal (EP395) on Allergen-Induced Eosinophil Infiltration into the Lung.

Journal: Lung

Published: February 19, 2026

In Vitro and In Vivo Efficacy of Epithelial Barrier-Promoting Barriolides as Potential Therapy for Ulcerative Colitis.

In Vitro and In Vivo Efficacy of Epithelial Barrier-Promoting Barriolides as Potential Therapy for Ulcerative Colitis.

Journal: Biomedicines

Published: December 01, 2025

Promoting immune defensive responses of epithelial cells in airway disease.

Promoting immune defensive responses of epithelial cells in airway disease.

Journal: Frontiers in allergy

Published: September 02, 2025

The Non-Antibacterial Effects of Azithromycin and Other Macrolides on the Bronchial Epithelial Barrier and Cellular Differentiation.

The Non-Antibacterial Effects of Azithromycin and Other Macrolides on the Bronchial Epithelial Barrier and Cellular Differentiation.

Journal: International journal of molecular sciences

Published: February 04, 2025

Effect of EP395, a novel anti-inflammatory macrolide, in an inhaled lipopolysaccharide challenge model in healthy volunteers: a randomised controlled trial.

Effect of EP395, a novel anti-inflammatory macrolide, in an inhaled lipopolysaccharide challenge model in healthy volunteers: a randomised controlled trial.

Journal: Pulmonary pharmacology & therapeutics

Published: February 03, 2025

Effects of EP395, a novel macrolide, on acute neutrophilic airway inflammation.

Effects of EP395, a novel macrolide, on acute neutrophilic airway inflammation.

Journal: Pulmonary pharmacology & therapeutics

Published: January 09, 2025

A novel macrolide, EP395, with reduced antibacterial activity and an enhancing effect on respiratory epithelial barrier.

A novel macrolide, EP395, with reduced antibacterial activity and an enhancing effect on respiratory epithelial barrier.

Journal: Pulmonary pharmacology & therapeutics

Published: January 08, 2025

Immune Modulatory Profile of the Pateamines PatA and Des-Methyl Des-Amino PatA.

Immune Modulatory Profile of the Pateamines PatA and Des-Methyl Des-Amino PatA.

Journal: International journal of molecular sciences

Published: September 16, 2024

Immune-modulatory effects of Spindlin-1 inhibitors.

Immune-modulatory effects of Spindlin-1 inhibitors.

Journal: Clinical and experimental immunology

Published: June 10, 2024

IL-2-mediated hepatotoxicity: knowledge gap identification based on the irAOP concept.

IL-2-mediated hepatotoxicity: knowledge gap identification based on the irAOP concept.

Journal: Journal of immunotoxicology

Published: April 05, 2024

Of rodents, research and relationships: a pharmacological odyssey.

Of rodents, research and relationships: a pharmacological odyssey.

Journal: Inflammopharmacology

Published: March 28, 2024

Identification of CRTH2 as a New PPARγ-Target Gene in T Cells Suggested CRTH2 Dependent Conversion of Th2 Cells as Therapeutic Concept in COVID-19 Infection.

Identification of CRTH2 as a New PPARγ-Target Gene in T Cells Suggested CRTH2 Dependent Conversion of Th2 Cells as Therapeutic Concept in COVID-19 Infection.

Journal: ImmunoTargets and therapy

Published: February 09, 2024

Showing 1-12 of 91

Last Updated: 09/26/2026